1.T-T Shi, et al. Alterations in the intestinal microbiota of patients with severe and active Graves' orbitopathy: a cross-sectional study. J Endocrinol Invest.2019 Aug;42(8):967-978.
2.T-T Shi, et al. Comparative assessment of gut microbial composition and function in patients with Graves' disease and Graves' orbitopathy. J Endocrinol Invest. 2021 Feb;44(2):297-310.3.T-T Shi,et al. The Potential Link between Gut Microbiota and Serum TRAb in Chinese Patients with Severe and Active Graves' Orbitopathy. Int J Endocrinol. 2019 Dec 18;2019:9736968.4.Z Xin, et al. A genome-wide DNA methylation analysis in peripheral blood from patients identifies risk loci associated with Graves' orbitopathy. J Endocrinol Invest. 2018 Jun;41(6):719-727.5.T-T Shi,et al. Identifying and Validating Genes with DNA Methylation Data in the Context of Biological Network for Chinese Patients with Graves' Orbitopathy. Int J Endocrinol. 2019 Mar 14;2019:6212681.6.Y-F Hu,et al.Preliminary evidence of the association between DNAm and orbital volumetry in GO. Endocr Connect. 2020 Jun 1;9(7):617–26.